Management of Hypoechoic Non-Tender Testicular Mass
A hypoechoic testicular mass must be managed as malignant until proven otherwise, requiring immediate serum tumor markers (AFP, hCG, LDH) and scrotal ultrasound with Doppler, followed by radical inguinal orchiectomy as definitive treatment in most cases. 1
Immediate Diagnostic Work-Up
Serum Tumor Markers
Draw serum tumor markers before any intervention, including orchiectomy 1:
- Alpha-fetoprotein (AFP) - half-life ~5-7 days
- Human chorionic gonadotropin (hCG) - half-life ~1-3 days
- Lactate dehydrogenase (LDH)
These markers are critical for diagnosis, staging, prognosis, and monitoring treatment response. Repeat markers 7 days post-orchiectomy to assess half-life kinetics 2.
Imaging
Scrotal ultrasound with Doppler is mandatory 1. Key findings:
- Hypoechoic mass with vascular flow is highly suggestive of malignancy 1
- Assess size, location, multifocality
- Evaluate contralateral testis
- Do not use MRI as initial evaluation 1
Pre-Treatment Counseling
Before definitive management, counsel regarding 1:
- Risks of hypogonadism and infertility
- Offer sperm banking - most cost-effective fertility preservation strategy 3
- Consider sperm banking before orchiectomy in patients with:
- No normal contralateral testis
- Known subfertility
- Bilateral lesions
Definitive Management Algorithm
Standard Approach: Radical Inguinal Orchiectomy
Radical inguinal orchiectomy is the standard of care 2, 4:
- Perform through inguinal incision only - never scrotal approach 2
- Resect testis with spermatic cord at internal inguinal ring
- Avoid scrotal violation - associated with higher local recurrence 4
Special Consideration: Small Masses (<2 cm)
Critical nuance: 50-80% of non-palpable masses <2 cm are benign 1. Research shows malignancy rates may be as low as 13-21% in masses ≤2 cm 5.
Management options for small masses with normal tumor markers 1:
- Repeat ultrasound in 6-8 weeks (for indeterminate findings)
- Radical inguinal orchiectomy
- Testis-sparing surgery with intraoperative frozen section (highly selected cases)
Testis-Sparing Surgery Criteria
Consider only in highly selected patients 1, 3, 4:
- Mass <2 cm
- Normal tumor markers (AFP and hCG)
- One of the following:
- Solitary/functionally solitary testis
- Bilateral testicular tumors
- Equivocal ultrasound/physical exam findings
- Must have intraoperative frozen section analysis 2
- Patient must have excellent compliance for follow-up 4
Important caveat: Testis-sparing surgery should only be performed in experienced centers with expert pathologists, as frozen section concordance with final pathology is critical 3, 2.
Post-Orchiectomy Staging
After histologic diagnosis, complete staging with 3:
- CT chest/abdomen/pelvis with contrast - mandatory for all patients
- Brain MRI if poor-prognosis features (high hCG, choriocarcinoma, multiple lung metastases, cerebral symptoms)
- Do not routinely use PET scanning 3
Common Pitfalls to Avoid
- Never perform scrotal biopsy or scrotal incision - increases local recurrence risk 2, 4
- Never delay tumor marker assessment - must be drawn before orchiectomy 1
- Do not skip fertility counseling - address before any treatment 1
- Avoid testis-sparing surgery outside experienced centers - high risk of inadequate frozen section analysis 3, 2
- Do not assume all hypoechoic masses are malignant - particularly masses <5 mm may be safely observed with serial imaging in select cases 6, 7
Surveillance Option for Very Small Masses
For incidental masses <5 mm with normal tumor markers and no vascular flow, surveillance with serial ultrasound may be considered 6, 7:
- Research shows these lesions rarely grow (mean growth rate -0.01 mm/year) 6
- All malignant lesions in one series were >5 mm and demonstrated vascularity 6
- Requires excellent patient compliance and close follow-up
- Any growth, positive markers, or concerning features warrant immediate surgical exploration
However, the safest approach remains radical orchiectomy given the high cure rate and excellent prognosis when treated early 1, 2.